-
New shared decision-making tool (SDM) by the World Federation of Hemophilia
The World Federation of Hemophilia SDM Tool is an interactive decision-support system designed to facilitate discussions regarding treatment options between people with hemophilia A or B and/or caregivers and...
Update on gene therapy for hemophilia
Montreal, August 10, 2023 – Gene therapies for hemophilia A and B continue to move closer to becoming reality. Health Canada is currently evaluating two gene therapies for hemophilia...
Patient satisfaction survey
The Canadian bleeding disorder treatment centres participed in a rigorous self-assessment of their services from November 2022 to February 2023. IT IS NOW TIME TO HEAR FROM PATIENTS AND...
Update on the 1986-1990 Hepatitis C Compensation Program
As the result of the latest actuarial study to the end of the year 2019, the Joint Committee announced in early 2021 that the Fund of the 1986-1990 Hepatitis...
-
-
-
Important survey about hemophilia B gene therapy – THE CLOCK IS TICKING!
-
-
The Serbia-Manitoba Chapter twinning partnership receives the WFH 2022 Twins of the Year award!
-
-
2023 recipients of the James Kreppner Memorial Scholarship and Bursary Program
-
Health Canada approves Alhemo (concizumab) for FIX inhibitors
-
-
